möLab BTM Test

The mö-screen BTM test is an immunochromatographic test that enables the differential detection of the bladder tumor marker hCFHrp and hemoglobin in urine. This test is an important component in preventive health care, to detect possible risks for bladder cancer at an early stage. Early detection of the disease offers the best chance of cure. The mö-screen BTM test provides a qualitative result in only 9 minutes and offers high sensitivity (57-97%) and specificity (72%). The test is easy to use and comes with complete accessories, including a disposable pipette and urine cup.

Important Note: For healthcare professionals only.
The test should only be performed and interpreted by a physician or a person authorized by a physician. Medical laypersons may use and interpret the test incorrectly. 

Product details

• Rapid test for the determination of the bladder tumor marker hCFHrp (BTM/BCM) and hemoglobin in urine 
• Immunochromatographic cassette test for qualitative detection
• For the diagnosis of bladder carcinoma
• Test result in only 9 minutes
• Incl. pipettes and urine cup
• High sensitivity (57-97 %) and specificity (72 %)
• Sample material: urine
• Sample volume: approx. 100 μl (3 drops) 
• Measuring time: 9 minutes
• Measuring method: chromatographic
• Detection limit: hemoglobin 250 ng/ml 
• Storage temperature: 2-30 °C
• Long shelf life of unopened test cassettes (up to 24 months)

Scope of delivery

• 10 möLab BTM tests consisting of:
• 10 test cassettes
• 10 pipettes
• 10 urine cups